Forecasts next-decade innovations—emerging modalities, automation, AI, and coordinated investment strategies that will shape a sustainable CGT ecosystem. The development of the cell and gene therapy (CGT) ecosystem depends on the bridge between public institutions, private investors, and industry stakeholders. At the Cell & Gene Therapy World 2026 Conference, leaders from government agencies, capital venture, biopharma, and research organizations will discuss how strategic partnerships and new finance models are advancing the CGT ecosystem.